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1 Introduction
The World Health Organization reports that 347 million
people worldwide have diabetes [1] and projects that dia-
betes will be the 7th leading cause of death in 2030 [2], de-
spite the advancing modern medical science and technol-
ogy [3,4]. Tight glycemic control is essential to prevent or
reduce life-threatening hyper- and hypoglycemic crises
causing serious long-term complications [5]. Using a per-
sonal blood glucometer with an enzymatically-active dis-
posable test strip, enables diabetic patients to monitor
their glucose levels by obtaining a small drop of capillary
blood from their fingertips or forearms with a convention-
al lancet. While minimum of four measurements of glu-
cose per day is recommended to maintain normal levels
of glucose in blood [6], up to eight checks per day are
recommended for children and adolescents with Type
1 diabetes on insulin treatment.7 Pricking the finger tip
for many times a day can limit patient compliance and
develop massive scarring/callous formation and loss of
sensibility/perception hindrance. Consequently, it may
lead to suboptimal blood glucose control and induce hy-
poglycemia. Therefore, the development and availability
of a pain-free glucose measuring device could greatly in-
crease patient compliance and maintain optimal glucose
control.
Tear glucose measurements have been suggested as an
alternative method to monitor glucose level. Tear glucose
measurement techniques mandate a low micromolar
LOQ, high selectivity over potential interferences such as
ascorbic acid, uric acid and acetaminophen, and measure-
ment within microliter or sub-microliter sample volume.
Since several studies have shown that there may be a clini-
cally useful correlation between blood and tear glucose
levels [7–9], more detailed studies are necessary to con-
firm the potential utility of tear glucose measurements to
help maintain optimal glucose control. We recently re-
ported [10] that Roches Accu-Chek blood glucose test
strips are able to measure glucose levels in tear samples
with adequate sensitivity (0.127 nA/mM) and selectivity
with 13 % error (n=3) for 25, 50 and 75 mM glucose in
the presence of 10 mM acetaminophen, 100 mM ascorbic
acid, and 100 mM uric acid. In this earlier work, the
Roche test strips were used for measurement of glucose
concentration in tears from nine normal (non-diabetic)
fasting human subjects and reported glucose values were
within the range of 5–148 mM (mean=47 mM, median=
43 mM), a similar range to that reported by Asher and co-
workers using an LC-MS technique.8 Herein, we utilize
bulk phase solution experiments with different enzymes,
strip-based screen printed electrode materials and media-
tors to explain why the Roche test strips exhibit such ex-
cellent detection limits and selectivity compared to all
other strips examined in our earlier studies [10]. Results
indicate that the unique combination of pyrroloquinoline
quinone dependent glucose dehydrogenase (PQQ-GDH)
as the active enzyme and a nitrosoaniline derivative as
the electron transfer mediator are the key components of
this test strip that yield the required sensitivity and selec-
tivity to accurately measure low glucose levels in tear
fluid.
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Abstract : Tear glucose measurements have been suggest-
ed as a potential alternative to blood glucose monitoring
for diabetic patients. While previous work has reported
a correlation between blood and tear glucose levels in
humans, this link has not been thoroughly established and
additional clinical studies are needed. We recently report-
ed that Roches electrochemical Accu-Chek blood glu-
cose test strips exhibit far superior analytical performance
over other commercial brands, with the low detection
limit and high selectivity required for quantitating tear
glucose levels. Herein, we evaluate the origin of the high
sensitivity and selectivity of the Roche test strips and
show that the use of pyrroloquinoline quinone (PQQ)-de-
pendent glucose dehydrogenase (GDH) as an active
enzyme reagent in combination with a nitrosoaniline de-
rivative as an electron transfer mediator are primarily re-
sponsible for the low limit of quantification (LOQ) (ca.
9 mM) and enhanced selectivity achieved with these strips.
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2 Experimental
2.1 Chemicals and Reagents
d-(+)-Glucose, glucose oxidase from A. niger (149.8 U/
mg), sodium chloride (NaCl), potassium ferricyanide(III)
(K3Fe(CN)6), potassium chloride (KCl), sodium phos-
phate dibasic (Na2HPO4), potassium phosphate monoba-
sic (KH2PO4), l-ascorbic acid, uric acid sodium salt, and
acetaminophen were purchased from Sigma-Aldrich (St.
Louis, MO). FAD (flavin adenine dinucleotide)-depen-
dent glucose dehydrogenase from Aspergillus sp. (1180 U/
mg) was obtained from Sekisui Enzymes (Lexington,
MA). PQQ-dependent glucose dehydrogenase (808 U/
mg) was a product of Toyobo Enzyme (Osaka, Japan). O-
methoxy-[N,N-bis-(2-hydroxyethyl)]-p-nitrosoaniline (ni-
trosoaniline derivative) (see Figure 1) was generously do-
nated by PharmaBlock R&D Co. Ltd (Nanjing, China).
2.2 Chemicals and Reagents
A four-channel Biostat (ESA Biosciences Inc., Chelms-
ford, MA) was used to measure the amperometric re-
sponse to glucose solutions (0–5 mM) containing en-
zymes, mediators and/or potential interfering species
(easily oxidizable species at applied potentials) using an
applied potential of +150 mV. For testing electrodes with
different materials (palladium, gold and carbon), com-
mercially available glucose test strips from Bayer, Roche
Diagnostics and Abbott were purchased over the counter
and the top housing layers were removed to expose the
electrochemical sensing sites. Each of these strips uses
palladium, gold and carbon as the working electrode ma-
terial, respectively. The exposed surfaces of the strips
were then washed thoroughly with deionized water and
ethanol to remove any deposited chemical reagents on
the surface of electrodes before use in bulk solution ex-
periments.
Individual stock solutions of 1.5 M glucose, 25 mM as-
corbic acid, 25 mM uric acid and 25 mM of acetamino-
phen were made in phosphate saline buffer (PBS) solu-
tion containing 137 mM NaCl, 2.7 mM KCl, 10 mM
Na2HPO4, and 2 mM KH2PO4, adjusted pH to 7.4 with
1 M NaOH. Standard solutions were prepared by dilution
of the stock solutions using PBS solution for calibrations
of glucose. Solutions of 0.5 mM ascorbic and uric acid
and 0.2 mM acetaminophen (freshly made each day) were
used to examine the cumulative effect of these potential
interference species on the accuracy of glucose measure-
ments. The reported average levels of ascorbic and uric
acid in tears are 206.2 and 6846 mM, respectively
[11,12]. A 0.2 mM acetaminophen solution was also
tested assuming that this species may be present in tears
at a relative dilution ratio similar to blood glucose, if the
patient was using this drug. Stock solutions of the various
enzymes and mediators were made in PBS solution in the
same way.
2.3 Electrochemical Measurements
Various glucometer strips for which the reagents layers
were removed and the electrodes first exposed and
cleaned were used as biamperometric detectors in bulk
solution phase experiments. Each of the strips has two
identical electrodes that are utilized for glucose detection
with one electrode employed as the working electrode
(apply positive voltage to oxidize reduced form of media-
tor formed from enzymatic oxidation of glucose and/or
reduction of mediator by potential interferent species
that can directly reduce the mediator) and the other serv-
ing as the pseudo reference/counter electrode. The
cleaned and uncovered electrode ends of the various
strips were placed in 5 mL of PBS buffer within a vial,
and a small magnetic stir bar was utilized to mix the solu-
tion. Different mediators (e.g., ferricyanide or the nitro-
soaniline derivative (see Figure 1)) alone or in combina-
tion with different glucose oxidizing enzymes (at near
equivalent activity in term of Units/mL) were added to
the PBS solution for testing response to ascorbic acid,
uric acid and acetaminophen, as well as to different con-
centrations of glucose. The Biostat electrochemical ana-
lyzer was used to apply the indicated voltage between the
two electrodes of the strips and to monitor the resulting
current as a function of time after addition of glucose or
test interference species.
3 Results and Discussion
A schematic of a generic blood glucometer test strip
when used for monitoring glucose in tear fluid is illustrat-
Fig. 1. Structures of (a) ferricyanide and (b) O-methoxy-[N,N-bis-(2-hydroxyethyl)]-p-nitrosoaniline that were examined as electron
transfer mediators in this work.
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ed in Figure 2. A number of different glucose-oxidizing
enzymes have been used to prepare conventional glucose
biosensors for measuring glucose concentration in whole
blood. Glucose oxidase (GOX) has been widely used to
catalyze oxidation of glucose on or close to the electrode
surface, which can be followed by amperometric monitor-
ing of liberated H2O2 or the consumed O2. However,
monitoring peroxide production when using GOX re-
quires a high applied potential (+600 mV) [13], at which
potential interferents can also be easily oxidized. Fortu-
nately, via the aid of electron transfer mediators the ap-
plied potential required can be significantly lowered to
partially reduce the interference problem. Indeed, effi-
cient electron transfer mediators such as ferrocene and its
derivatives were originally used for the enzymatic reac-
tion catalyzed by GOX and applied in Abbotts Medi-
sense Precision Q.I.D. blood glucometer test strips back
in the early 1990s. However, since then, other mediators
including potassium ferricyanide, osmium complexes and
nitrosoaniline derivatives have become the mediators of
choice and are the ones most widely used in current com-
mercial blood glucometer test strips. In fact, several com-
mercial strips (e.g., Johnson and Johnson One Touch,
Bayer Contour, etc.) utilize potassium ferricyanide as
the mediator in the strip configuration illustrated in
Figure 2. Beyond glucose oxidase, two different types of
glucose dehydrogenase (GDH) enzymes are also often
employed to create blood glucometer strips; FAD depen-
dent GDH, and PQQ dependent GDH. The Roche test
strips that were found to be so useful for tear glucose
measurements utilize a unique combination of gold work-
ing/counter electrodes, PQQ-GDH as an active enzyme
and a nitrosoaniline derivative (see Figure 1) as an elec-
tron transfer mediator. This strip is able to measure low
concentrations glucose found in tears selectively in the
presence of electroactive interferents [10]. An optimal
applied voltage of 150 mV between the two gold electro-
des within the Roche strips for calibration over the 1–
100 mM glucose concentration range was found to yield
the lowest % errors from such potential interferent spe-
cies [10].
To better understand the enhanced selectivity over po-
tential interferences of the Roche Accu-Chek glucometer
strips vs. other common brands when applied for tear
measurements, we first examined the response of interfer-
ing species (ascorbic acid, uric acid and acetaminophen)
on three different electrode strip materials (palladium,
gold and carbon) in terms of the steady-state amperomet-
ric responses in the presence of two different electron
transfer mediators, potassium ferricyanide and the nitro-
soaniline derivative (Figure 1), in bulk solution experi-
ments. As stated above, potassium ferricyanide is the
most widely used electron transfer mediator at present
and therefore it was chosen to be compared directly to
the nitrosoaniline derivative. Our aim was to determine
which combination yields the least current from oxidation
of the potential interferents. An applied potential of
+150 mV between the two strip electrodes was chosen
because it is the optimal potential found previously to
achieve the highest selectivity for glucose for the Roche
test strips with nitrosoaniline derivative as an electron
transfer mediator [10]. Further, this applied potential is
close to the +200 mV value that is generally used for test
strips employing potassium ferricyanide as an electron
transfer mediator [14].
As shown in Figure 3, on gold-printed electrodes,
a large increase in current is observed at the 80 s mark
when ascorbic acid is added to a stirred PBS solution
(pH 7.4) to achieve a final concentration of 0.5 mM ascor-
bic acid for sensor strips with either potassium ferricya-
nide or nitrosoaniline derivative as the added redox medi-
ators in the bulk solution and with +150 mV applied be-
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Fig. 2. Schematic of blood glucometer test strip and its potential application for monitoring glucose levels in a tiny volume of tear
fluid. In addition to gold and carbon electrodes utilized in a bioamperometric sensing mode, Pd and other metals have been em-
ployed.
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tween working and reference/counter electrode of the
strips. It should also be noted that the level of currents
observed toward ascorbic acid is much greater when ferri-
cyanide is used vs. when an equivalent concentration of
nitrosoanaline deriative is employed in the bulk solution
(10 mM) under the exact same experimental conditions.
However, when nitrosoaniline derivative is employed
(Figure 3b), 0.5 mM ascorbic acid is the only potential in-
terferent species yielding a significant current at
+150 mV applied potential (primarily due to reduction of
the mediator by ascorbate). As shown in Figure 3b,
0.5 mM uric acid and 0.2 mM acetaminophen are not
electro-oxidized at all when the nitroaniline derivative is
used at 10 mM levels in the PBS solution. In contrast,
when potassium ferricyanide is employed as mediator,
relatively large responses from uric acid and acetamino-
phen are observed at an applied potential of +150 mV
(Figure 3a). This same behavior is also observed for pal-
ladium and carbon-printed electrodes (data not shown).
When using potassium ferricyanide as mediator, all three
types of electrodes (palladium, gold and carbon) exhibit
a significant current increase in the presence of potential
interferents, while in the presense of the nitrosoaniline
derivative, 0.5 mM uric acid and 0.2 mM acetaminophen
do not yield an increase in anodic current. It is well
known that, ascorbic acid can react with the mediators in
their oxidized form to form reduced mediator which can
then be oxidized electrochemically. Our results indicate
that the nitrosoaniline derivative is much more inert to
these interfering species than potassium ferricyanide,
which makes the nitrosoaniline derivative a better elec-
tron transfer mediator for more selective glucose meas-
urements in blood as well as in tear fluid.
Initial screening of all possible combinations of differ-
ent electrode materials and mediators indicated that the
use of gold working/counter electrodes along with the ni-
trosoanaline derivative is the only combination that ex-
hibits the optimal selsectivity over potential interferents
in the bulk phase experiments using the printed electro-
des of several commercial brands of test strips. Conse-
quently, this combination was utilized in further studies
to measure low-end glucose concentrations using differ-
ent glucose oxidizing enzymes as catalysts for detection
of glucose.
Toward this end, three different enzymes used for glu-
cose measurements were examined in the bulk phase ex-
periments using biamperometric detection with various
glucometer strip electrodes. The enzymes tested included
glucose oxidase, as well as glucose dehydrogenases with
two different cofactors/prosthetic groups, flavin adenine
dinucleotide (FAD) and pyrroloquinoline quinone
(PQQ). The enzymes were added to the PBS buffer alone
with either potassium ferricyanide or nitrosoaniline deriv-
ative, and the biamperometric response toward additions
of glucose concentrations in the range of 0–5 mM were
recorded. The response curves toward glucose were ob-
tained initially in PBS without any interfering species
present. As shown in Figure 4a, with 125 U/mL FAD- or
PQQ-dependent GDHs, coupled with 20 mM potassium
ferricyanide in the test solution and gold electrodes as the
biamperometric detectors (at an applied potential of
+150 mV), significant amperometric signals are observed
for low-end glucose concentrations in the range of
0–0.2 mM. In contrast, when using GOX at the same
U/mL concentrations, there is very poor sensitivity to
changes in glucose concentrations, with amperometric re-
sponse observed only in the higher concentrations range
(0.5 mM). In the case of the nitrosoaniline derivative
(Figure 4b), only the PQQ-GDH catalyst yields signifi-
cant amperometric response to glucose in the low concen-
tration range required for tear glucose measurements. It
is important to note that 20 mM of both mediators was
used for these experiments, instead of 10 mM, in order to
have a sufficient level of mediator necessary to oxidize
high-end glucose concentrations.
The far superior glucose sensitivity observed in the
above experiments when using both FAD- and PQQ-de-
pendent GDH may relate to their lower Michaelis
Menten constant KM values, compared to the other en-
zymes that catalyze glucose oxidation. The lower KM re-
sults in an increase in the rate of reaction at a lower glu-
cose level and, therefore, increased catalytic current from
Fig. 3. Comparison of dynamic amperometric responses (at room temperature; applied potential= +150 mV) from the interferents
(0.5 mM ascorbic acid (AA), 0.5 mM uric acid (UA) and 0.2 mM acetaminophen (AM)) in the presence of 10 mM potassium ferricya-
nide (a) or 10 mM nitrosoaniline derivative (b) in PBS (pH 7.4, 0 mM glucose) on gold-printed electrodes. Background response from
10 mM potassium ferricyanide (a) and nitrosoanaline derivative in PBS solution is recorded between 20–80 s. Response from interfer-
ents are recorded between 80–140 s.
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oxidation of the reduced mediator at the working elec-
trode at lower glucose concentrations. Indeed the Mi-
chaelisMenten constant KM values toward glucose of
GOX, FAD-GDH, NAD-GDH, and PQQ-GDH are re-
ported to be 27, 0.46, 10 and 0.38 mM, respectively [15–
18]. Hence, there is a significantly lower KM value for the
two enzymes that exhibit the most sensitive response to
glucose levels in the bulk solution phase experiments.
Further, from the patent literature [19], it is known that
Roche utilizes a recombinant form of PQQ-GDH in
order to avoid interference from maltose that can cause
errors with blood glucometer devices that utilize PQQ-
GDH as the active enzyme. Hence, it is possible that the
recombinant form of PQQ-GDH utilized in the Accu-
Chek strips may have an even lower KM compared to the
0.38 mM value reported for the native enzyme.
Although use of FAD- and PQQ-dependent GDHs in
combination with potassium ferricyanide as the electron
transfer mediator exhibits very good sensitivity for low
concentration detection of glucose, the use of potassium
ferricyanide is not desired since a considerable amount of
current is detected from oxidation of ascorbic acid, uric
acid and acetaminophen using this mediator (see Fig-
ure 3a, above). Indeed, when potassium ferricyanide is
employed as the electron transfer mediator, the lower de-
tection limit for the bulk phase experiments is only ca.
0.5 mM glucose, when 0.5 mM ascorbic acid, 0.5 mM uric
acid and 0.2 mM acetaminophen are all present in the
test solution (data not shown).
As stated above, when using nitrosoaniline derivative
as the electron transfer mediator (Figure 4b), PQQ-GDH
produces the most sensitive response to glucose among
all three enzymes tested, especially in the desired tear
glucose measuring range (0–0.2 mM). With the nitrosoa-
niline derivative, GOX and FAD-GDH only yield am-
perometric response to glucose in the higher range of glu-
cose levels (0.5 mM). It should be noted that for same
enzyme, the sensitivity differs significantly with the differ-
Fig. 4. Dynamic amperometric response (at room temperature; applied potential = +150 mV) for changes in glucose concentration
(0–5 mM) in the presence of (a) 20 mM potassium ferricyanide and (b) 20 mM nitrosoaniline derivative in PBS solution (pH 7.4) with
125 U/ml glucose oxidase (GOX), FAD- (FAD-GDH), and PQQ-dependent glucose dehydrogenase (PQQ-GDH). The activities of
the enzymes were 149.8 U/mg, 1180 U/mg and 808 U/mg, respectively. Insets: Current response from low-end glucose concentrations
(0–0.2 mM). Within the figure, the indicated concentrations represent the total concentration of glucose at each arrow point in time.
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ent mediators. Our results indicate that for FAD-GDH,
potassium ferricyanide is a better mediator than nitrosoa-
niline for facilitating the electron-transfer process. How-
ever, for PQQ-GDH, the use of the nitrosoaniline deriva-
tive is required to obtain enhanced sensitivity, and the se-
lectivity over interfering species is far superior to the
combination of FAD-GDH and potassium ferricyanide.
Another advantage of mediator facilitated PQQ-GDH
sensing system is its oxygen independence. We compared
glucose calibrations (0–3 mM) in bulk solution containing
PQQ-GDH and nitrosoaniline derivative in the presence
of ambient oxygen concentration (~21%) and with no
oxygen present by purging with N2. The sensitivity and
low detection limit in both experiments are nearly identi-
cal, suggesting that for amperometric glucose measure-
ments, use of the combination of PQQ-GDH and the ni-
trosoaniline derivative yields signals that are independent
of oxygen levels in the solution (data not shown).
The electrochemical response of the strips made with
gold electrodes to glucose in the presence of ascorbic acid
in the bulk solution was also examined using the optimal
combination of PQQ-GDH and the nitrosoaniline deriva-
tive. The previous results (see Figure 3) suggested that as-
corbic acid still poses a problem and that the combination
of PQQ-GDH, nitrosoaniline derivative and gold elec-
trode detection cannot avoid oxidation of ascorbic acid at
an applied potential of +150 mV. As shown in Figure 5a,
with 10 mM nitrosoaniline derivative present in solution,
the glucose sensitivity at low concentrations is better in
the presence of 0.1 mM ascorbic acid than 0.5 mM ascor-
bic acid. However, as also shown in Figure 5a, the inter-
ference effect from ascorbic acid can be partially mini-
mized by controlling the concentration of the mediator,
through which the reaction between a lower concentra-
tion of nitrosoaniline derivative (3.7 mM) and 0.1 mM as-
corbic acid yields less anodic current than the reaction
between 10 mM nitrosoaniline derivative and 0.1 mM as-
corbic acid. Figure 5b shows the glucose calibration
curves for the gold-printed electrodes coupled with PQQ-
GDH and 3.7 mM nitrosoaniline derivative (in bulk solu-
tion) in the absence and presence of 0.1 mM ascorbic
acid. Although in the range of 0–50 mM glucose, the oxi-
dation current from ascorbic acid is high, at the 50 mM
glucose level, the current increase by the presence of
0.1 mM ascorbic acid is ca. 27 %, corresponding to
+13 mM error in the glucose measurement. At 200 mM
glucose, the error from ascorbic acid is only 1%. Howev-
er, in the prior work with fully assembled Roche Accu-
Chek strips [10], we found much lower errors when ascor-
bate at 0.1 mM in combination with acetaminophen and
uric acid was tested as an interference solution in the
presence of 50 mM glucose (combined error from interfer-
ences<13% [10]). Since in the fully assembled commer-
cial blood glucometer strip, the PQQ-GDH and nitrosoa-
niline derivative (1 :2 by weight) are coated over the sur-
face of the gold electrodes within a polymeric matrix con-
taining thickeners, stabilizers, detergents, and other ad-
junct materials, and the current is recorded after 5 s after
wicking of the test samples into the strips, there may well
be some partial mass transport rejection of ascorbic acid
into the enzyme/mediator layer that further enhances se-
lectivity compared to the homogeneous experiments re-
ported in this work.
4 Conclusion
In this report, we have shown that that the ability of
Roche Accu-Chek test strips to be used to measure mM
levels of glucose without substantial interference from
other redox active species is due to the unique combina-
tion of using PQQ-GDH as the active enzyme in combi-
nation with nitrosoaniline derivative as an electron trans-
fer mediator. The low KM value of this enzyme, coupled
with the inability of uric acid and acetaminophen to
reduce the nitrosoaniline mediator and yield electrochem-
ical response in a biamperometric measurement mode,
appear to be the key elements that provide the excellent
LOQ value and selectivity of these strips. These findings
Fig. 5. (a) Dynamic amperometric response (at room temperature; applied potential= +150 mV) for increasing glucose concentra-
tions (0–1 mM) in the presence of 10 and 3.7 mM nitrosoaniline derivative (ND), PQQ-dependent glucose dehydrogenase with various
concentration of ascorbic acid (AA; 0, 0.1 and 0.5 mM) in PBS solution (pH 7.4). Within the figure, concentrations refer to the total
concentration of glucose made at each arrow point in time. (b) Dependence of steaedy-state current on glucose concentration in the
presence of 0.1 mM ascorbic acid (circles) and without ascorbic acid (squares).
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suggest that any future efforts to create specialized elec-
trochemical glucometer type test strips, specifically for
direct sampling of submicroliter quantities of tear fluid
from eyes, should utilize PQQ-GDH in combination with
O-methoxy-[N,N-bis-(2-hydroxyethyl)]-p-nitrosoaniline as
the reagents.
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